149 results
Page 3 of 8
6-K
EX-99.1
ppf73h0g2d7dqg7l4to
16 Nov 22
Third Quarter Interim Statement January – September
4:14pm
6-K
EX-99.1
etcoa
3 Nov 22
MorphoSys to Share New Data on Pelabresib and Monjuvi® (tafasitamab-cxix) in 14 Presentations at the American Society of Hematology Annual Meeting
9:40am
6-K
EX-99
g197z i37ngtca6r
27 Oct 22
Current report (foreign)
4:17pm
6-K
EX-99.1
wj12aga 0hf
28 Sep 22
Current report (foreign)
5:04pm
6-K
EX-99.1
4np7tk
31 Aug 22
MorphoSys appoints Tim Demuth as new Chief Research and Development Officer, following the retirement of Malte Peters
4:08pm
6-K
2iyxgx63
31 Aug 22
MorphoSys appoints Tim Demuth as new Chief Research and Development Officer, following the retirement of Malte Peters
4:08pm
6-K
EX-99.1
y4zjnn6ihl42 uuk3f
4 Aug 22
MorphoSys AG Reports Second Quarter and First Half 2022 Financial Results
9:06am
6-K
EX-99.2
o2cfjs
4 Aug 22
MorphoSys AG Reports Second Quarter and First Half 2022 Financial Results
9:06am
6-K
EX-99.1
w5z ase9dj
3 Aug 22
Half-Year Report JANUARY – JUNE 2022
4:36pm
6-K
EX-99.1
xuzqq
23 Jun 22
First Quarter Interim Statement JANUARY – MARCH
6:30am
6-K
EX-99.1
8qr4jji41zk3nfct
13 Jun 22
Current report (foreign)
4:07pm
6-K
EX-99.1
m5z tdk2y
10 Jun 22
Current report (foreign)
7:16am
6-K
EX-99.1
8u0naxy99
12 May 22
Current report (foreign)
10:53am
6-K
EX-99.1
4ax 90j5vvu6vv
5 May 22
MorphoSys AG Reports First Quarter 2022 Financial Results
9:17am
6-K
EX-99.2
s7ynx3k4xv
5 May 22
MorphoSys AG Reports First Quarter 2022 Financial Results
9:17am
6-K
EX-99.1
vtu2pj
23 Mar 22
Current report (foreign)
4:15pm
6-K
EX-99.1
i77t1 83hebeg8uqpj
22 Mar 22
Current report (foreign)
4:10pm
6-K
EX-99.1
k8pj1y g68
17 Mar 22
MorphoSys AG Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update
9:48am
6-K
EX-99.2
b0agz3ttyc cm287
17 Mar 22
MorphoSys AG Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update
9:48am
6-K
EX-99.1
7w6y5
16 Mar 22
Current report (foreign)
5:13pm